Compare MED & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MED | EARN |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Real Estate Investment Trusts |
| Sector | Consumer Staples | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.8M | 169.8M |
| IPO Year | 1996 | 2012 |
| Metric | MED | EARN |
|---|---|---|
| Price | $12.04 | $4.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $5.38 |
| AVG Volume (30 Days) | 105.7K | ★ 356.2K |
| Earning Date | 05-04-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 20.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $934,842,000.00 | N/A |
| Revenue This Year | N/A | $7.69 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.22 | $4.25 |
| 52 Week High | $14.67 | $5.77 |
| Indicator | MED | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 41.40 |
| Support Level | $10.01 | $4.29 |
| Resistance Level | $12.21 | $4.49 |
| Average True Range (ATR) | 0.42 | 0.07 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 27.52 | 2.38 |
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Ellington Credit Co The Fund is focused on acquiring and actively managing a portfolio of corporate CLOs, mainly mezzanine debt and equity tranches, which are typically collateralized by portfolios consisting mainly of below-investment-grade senior secured loans with a large number of discrete underlying borrowers across various industry sectors. Additionally, the Fund may also invest in CLO loan accumulation facilities, which are entities that acquire corporate loans and other similar corporate credit-related assets in anticipation of ultimately collateralizing a CLO transaction. The company's primary investment objectives are to generate attractive current income and risk-adjusted total returns for shareholders.